Bright Minds Biosciences Inc (DRUG)
EBITDA Growth
-124.08%
Quarterly · Period ending:
DRUG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-124.08%period ending
Latest reported-124.08%period ending
DRUG Quarterly EBITDA YoY % (-1864.91% → -124.08%)
Year-over-year change
High-resolution chart · PNG
DRUG ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -124.0837% | |
| -262.315% | |
| -10,706.144% | |
| -439.2995% | |
| -2,208.2132% | |
| -426.574% | |
| 104.2699% | |
| 50.0345% | |
| 117.2159% | |
| 72.6416% | |
| 28.0998% | |
| 48.9044% | |
| 100% | |
| 100% | |
| 100% | |
| 100% | |
| -1,864.9147% |